Clinical Trial Update: A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen [Phase 3]

View source ↗

Summary

Phase III trial comparing entecavir to lamivudine in adults with chronic hepatitis B has completed; the update notes the study status but does not provide resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• Epivir-HBV (lamivudine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis B | Phase 3 | Status: COMPLETED